(2009; 30 pages)
This chapter assesses how the current economic downturn is affecting drug prices and the affordability of medicines, particularly among vulnerable population groups. A related question concerns possible measures that could be adopted in Russia to facilitate access to essential drugs and ensure rational drug use. The chapter focuses on special issues of affordability and access. It also suggests the need for assessing the regulatory role of government in different areas of the pharmaceutical market. Such an assessment would provide policymakers, insurance providers, and healthcare institutions with an analysis of regulation’s impact on efficiency, quality, equity, and cost control.